
12/07/2025
Anthem Biosciences raises ₹1,016-Cr from anchor investors ahead of IPO
Anthem Biosciences operates as a technology-driven Contract Research, Development, and Manufacturing Organization (CRDMO) with end-to-end capabilities across drug discovery, development, and production.
Read more :- https://buff.ly/cCacCxg